Prokidney (PROK) Accumulated Depreciation (2021 - 2025)
Prokidney's (PROK) quarterly Accumulated Depreciation came in at $16.6 million in Q4 2025, up 50.04% year-over-year from $11.0 million in Q4 2024, and up 19.24% quarter-over-quarter from $13.9 million in Q2 2025.
Analysis
Prokidney (PROK) Accumulated Depreciation (2021 - 2025) Analysis & Trends
Prokidney (PROK) has reported Accumulated Depreciation for 5 consecutive years, with $16.6 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Accumulated Depreciation rose 50.04% year-over-year to $16.6 million in Q4 2025; TTM through Dec 2025 was $16.6 million, a 50.04% increase from a year earlier, with the FY2025 full-year figure at $16.6 million, up 50.04% from the prior year.
- Accumulated Depreciation was $16.6 million for Q4 2025 at Prokidney, up from $13.9 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $16.6 million in Q4 2025 and troughed at $2.3 million in Q4 2021.
- A 5-year average of $8.5 million and a median of $8.0 million in 2023 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation surged 108.41% in 2022 and jumped 44.36% in 2024, its largest moves.
- Over 5 years, Accumulated Depreciation stood at $2.3 million in 2021, then soared by 108.41% to $4.7 million in 2022, then soared by 62.32% to $7.6 million in 2023, then soared by 44.36% to $11.0 million in 2024, then soared by 50.04% to $16.6 million in 2025.
- The last three Accumulated Depreciation figures came in at $16.6 million (Q4 2025), $13.9 million (Q2 2025), and $12.4 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16.55 Mn |
| Jun 30, 2025 | 13.88 Mn |
| Mar 31, 2025 | 12.41 Mn |
| Dec 31, 2024 | 11.03 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | 9.40 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Dec 31, 2023 | 7.64 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Jun 30, 2023 | 5.98 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Sep 30, 2022 | 4.09 Mn |
| Dec 31, 2021 | 2.26 Mn |